BioSpace News Archive

Drug Development

Reanalysis of Key Trial Flags Fresh Safety Concerns for Amgen’s Repatha (Updated)

Amgen’s Repatha may cause cardiac harm, according to a reassessment of the biologic’s late-stage trial data.

January 4, 2023
·
3 min read
·
Tristan Manalac
Business

Belharra Launches with $130M From Versant, Genentech to Advance Chemoproteomics Platform (Updated)

Backed by Versant and Genentech, Belharra Therapeutics launched Wednesday with $130 million in total financing to advance its novel chemoproteomics platform.

January 4, 2023
·
2 min read
·
Rosemary Scott
Business

BrainStorm Preps for Type A NurOwn Meeting, Shakes Up C-Suite

BrainStorm Cell Therapeutics appoints a new co-CEO as it prepares for a January 11th Type A meeting for ALS hopeful NurOwn.

January 4, 2023
·
3 min read
·
Heather McKenzie
Drug Development

Geron Announces Positive Phase III Data, Likely to Seek FDA Approval in MDS

Geron announced Wednesday positive topline results from the Phase III IMerge trial evaluating the telomerase inhibitor, imetelstat, in lower-risk myelodysplastic syndromes patients.

January 4, 2023
·
2 min read
·
Lisa Munger
Executives Reunite at JPM as Biotech Kicks Off 2023

JP Morgan week is shaping up to approximate pre-pandemic attendance levels as executives return to San Francisco after two years of COVID-19-enforced absences.

January 4, 2023
·
5 min read
·
Gail Dutton
Drug Development

MD Anderson Delivers a Triple Punch to Pancreatic Cancer

In a recently published study, MD Anderson researchers achieved curative responses in pancreatic cancer models by targeting checkpoints in T cells and myeloid suppressor cells.

January 4, 2023
·
4 min read
·
Heather McKenzie
Drug Development

Market Appears to Question Competitive Prospects of Vera’s IgAN Therapy

Vera Therapeutics’ stock crashed following the reveal of data from a Phase IIb study of atacicept in IgAN.

January 4, 2023
·
2 min read
·
Tristan Manalac
BioCapital

Research That’s Using Data Science to Revolutionize Patient Care Highlighted in the January Issue of AACC’s The Journal of Applied Laboratory Medicine

In this special Data Science Issue, AACC’s The Journal of Applied Laboratory Medicine highlights the groundbreaking work that laboratory medicine experts are doing to advance patient care through data analytics and to make this game-changing technology a routine part of healthcare.

January 4, 2023
·
3 min read
BioCapital

Data Analytics Could Prevent Testing Bottlenecks During Future Pandemics

Breaking research demonstrates the efficacy of two data analytics-based strategies that clinical labs employed to meet COVID-19 testing demands during the height of the pandemic.

January 4, 2023
·
4 min read
Biotech Bay

Geron Corporation Announces Proposed Public Offering of Common Stock - Jan 04, 2023

Geron Corporation, a late-stage clinical biopharmaceutical company, announced that it intends to offer and sell $175 million of shares of its common stock in an underwritten public offering.

January 4, 2023
·
4 min read